Finished
AVIAR(MX-02) Robotic-assisted Percutaneous Coronary Intervention
NCT05981859 · Asan Medical Center · Updated 17 July 2024
- What is being tested
- Not stated
- For
- Percutaneous Coronary Intervention
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 19 years and older. About 21 people. The full rules are on the registry page.
- Where
- South Korea (2 sites)
- When
- Starts or started 16 Oct 2023, ends 26 April 2024. Registered 8 Aug 2023.
- Results
- None posted yet.
In the researchers' words
The objective of this study is to evaluate the safety and efficacy of the steerable catheter control system 'AVIAR(MX-02)', which remotely controls the guidewire and stent/balloon during the percutaneous coronary intervention (PCI) for those who have suspected coronary artery disease (CAD) and need PCI (for product approval from the MFDS).
Sites
- Asan Medical CenterSeoul, South Korea
- The Catholic University of Korea Eunpyeong St. Mary's HospitalSeoul, South Korea